AstraZeneca Employees Detained in China Over Alleged Illegal Activities
Chinese authorities have detained five current and former AstraZeneca employees in connection with potential illegal activities. The detained individuals, all Chinese citizens, worked in the company's oncology division to market cancer drugs. AstraZeneca acknowledged the investigation but declined to provide further information.
The police in China have detained five current and former employees of AstraZeneca for questioning about potential illegal activities, Bloomberg News reported on Thursday, citing people familiar with the matter.
In a statement, AstraZeneca acknowledged the investigation, stating, "We are aware a small number of our employees in China are under investigation and we have no further information to share at this point."
According to the report, the individuals being held are all Chinese citizens who marketed cancer drugs in AstraZeneca's oncology division.
ALSO READ
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Human Cost of Faster Work: Chinese Employees Weigh AI’s Promise Against Pay Fears
-
China's August Disasters Yield $5.38 Billion in Losses
-
China Strengthens Military Surveillance in Djibouti
Google News